Interleukin-17: A promoter in colorectal cancer progression

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Wu, Dang ^a   Wu, Pin ^a   Huang, Qi ^a   Liu, Yang ^a   Ye, Jun ^a   Huang, Jian ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17;

COLORECTAL TUMOR; DISEASE COURSE; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROGNOSIS; REVIEW;

COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; INTERLEUKIN-17; PROGNOSIS;

EID: 84893721316     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/436307     Document Type: Review

References (61)

1. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2013. CA: Cancer Journal for Clinicians 2013 63 1 11 30
2. Mantovani A., Allavena P., Sica A., Balkwill F., Cancer-related inflammation. Nature 2008 454 7203 436 444 2-s2.0-47949096781 10.1038/nature07205
3. Grivennikov S. I., Greten F. R., Karin M., Immunity, inflammation, and cancer. Cell 2010 140 6 883 899 2-s2.0-77950346282 10.1016/j.cell.2010.01.025
4. Ferrone C., Dranoff G., Dual roles for immunity in gastrointestinal cancers. Journal of Clinical Oncology 2010 28 26 4045 4051 2-s2.0-77956905415 10.1200/JCO.2010.27.9992
5. Klampfer L., Cytokines, inflammation and colon cancer. Current Cancer Drug Targets 2011 11 4 451 464 2-s2.0-79955585058 10.2174/156800911795538066
6. Terzić J., Grivennikov S., Karin E., Karin M., Inflammation and colon cancer. Gastroenterology 2010 138 6 2101.e5 2114.e5 2-s2.0-77951635438 10.1053/j.gastro.2010.01.058
7. Rouvier E., Luciani M. F., Mattei M. G., Denizot F., Golstein P., CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus Saimiri gene. Journal of Immunology 1993 150 12 5445 5456 2-s2.0-0027215897 (Pubitemid 23180658)
8. Kolls J. K., Lindén A., Interleukin-17 family members and inflammation. Immunity 2004 21 4 467 476 2-s2.0-5644277476 10.1016/j.immuni. 2004.08.018 (Pubitemid 39370503)
9. Iwakura Y., Ishigame H., Saijo S., Nakae S., Functional specialization of interleukin-17 family members. Immunity 2011 34 2 149 162 2-s2.0-79951743212 10.1016/j.immuni.2011.02.012
10. Kao C. Y., Chen Y., Thai P., Wachi S., Huang F., Kim C., Harper R. W., Wu R., IL-17 markedly up-regulates β -defensin-2 expression in human airway epithelium via JAK and NF- B signaling pathways. Journal of Immunology 2004 173 5 3482 3491 2-s2.0-4344688669 (Pubitemid 39142059)
11. Matsuzaki G., Umemura M., Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiology and Immunology 2007 51 12 1139 1147 2-s2.0-37549030879
12. Mays L. E., Ammon-Treiber S., Mothes B., Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism. Journal of Clinical Investigation 2013 123 3 1216 1228 10.1172/JCI65351
13. Hot A., Miossec P., Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Annals of the Rheumatic Diseases 2011 70 5 727 732 2-s2.0-79953310900 10.1136/ard.2010.143768
14. Shilling R. A., Wilkes D. S., Role of Th17 cells and IL-17 in lung transplant rejection. Seminars in Immunopathology 2011 33 2 129 134 2-s2.0-79956350378 10.1007/s00281-011-0257-9
15. Zhang Q., Liu S., Ge D., Zhang Q., Xue Y., Xiong Z., Abdel-Mageed A. B., Myers L., Hill S. M., Rowan B. G., Sartor O., Melamed J., Chen Z., You Z., Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models. Cancer Research 2012 72 10 2589 2599 10.1158/0008-5472.CAN-11-3795
16. Murugaiyan G., Saha B., Protumor vs antitumor functions of IL-17. Journal of Immunology 2009 183 7 4169 4175 2-s2.0-70449715722 10.4049/jimmunol.0901017
17. Chae W. J., Gibson T. F., Zelterman D., Hao L., Henegariu O., Bothwell A. L. M., Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 2010 107 12 5540 5544 2-s2.0-77950420796 10.1073/pnas. 0912675107
18. Cua D. J., Tato C. M., Innate IL-17-producing cells: the sentinels of the immune system. Nature Reviews Immunology 2010 10 7 479 489 2-s2.0-77954143695 10.1038/nri2800
19. Huber M., Brüstle A., Reinhard K., Guralnik A., Walter G., Mahiny A., Von Löw E., Lohoff M., IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proceedings of the National Academy of Sciences of the United States of America 2008 105 52 20846 20851 2-s2.0-58549094107 10.1073/pnas.0809077106
20. Yang X. O., Panopoulos A. D., Nurieva R., Seon H. C., Wang D., Watowich S. S., Dong C., STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. The Journal of Biological Chemistry 2007 282 13 9358 9363 2-s2.0-34247593586 10.1074/jbc.C600321200 (Pubitemid 47104613)
21. Hirahara K., Ghoreschi K., Laurence A., Yang X., Kanno Y., O'Shea J. J., Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine and Growth Factor Reviews 2010 21 6 425 434 2-s2.0-78649689761 10.1016/j.cytogfr.2010.10.006
22. Segura E., Touzot M., Bohineust A., Cappuccio A., Chiocchia G., Hosmalin A., Dalod M., Soumelis V., Amigorena S., Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013 38 2 336 348 10.1016/j.immuni.2012.10.018
23. Hirahara K., Ghoreschi K., Yang X. P., Takahashi H., Laurence A., Vahedi G., Sciumè G., Hall A. O., Dupont C. D., Francisco L. M., Chen Q., Tanaka M., Kanno Y., Sun H. W., Sharpe A. H., Hunter C. A., O'Shea J. J., Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 2012 36 6 1017 1030 10.1016/j.immuni. 2012.03.024
24. Raifer H., Mahiny A. J., Bollig N., Petermann F., Hellhund A., Kellner K., Guralnik A., Reinhard K., Bothur E., Huber M., Bauer S., Löhning M., Kiss E. A., Ganal S. C., Diefenbach A., Korn T., Lohoff M., Unlike α β T cells, γ δ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22. European Journal of Immunology 2012 42 12 3189 3201 10.1002/eji.201142155
25. Afzali B., Mitchell P. J., Edozie F. C., Povoleri G. A., Dowson S. E., Demandt L., Walter G., Canavan J. B., Scotta C., Menon B., Chana P. S., Khamri W., Kordasti S. Y., Heck S., Grimbacher B., Tree T., Cope A. P., Taams L. S., Lechler R. I., John S., Lombardi G., CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. European Journal of Immunology 2013 43 8 2043 2054 10.1002/eji.201243296
26. + T cells supports Th17-mediated autoimmune encephalomyelitis. Journal of Clinical Investigation 2013 123 1 247 260 10.1172/JCI63681
27. Takahashi N., Vanlaere I., de Rycke R., Cauwels A., Joosten L. A. B., Lubberts E., van den Berg W. B., Libert C., IL-17 produced by Paneth cells drives TNF-induced shock. Journal of Experimental Medicine 2008 205 8 1755 1761 2-s2.0-49249112420 10.1084/jem.20080588
28. + IL-17-producing T cells in ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America 2008 105 40 15505 15510 2-s2.0-55749098500 10.1073/pnas.0710686105
29. Tartour E., Fossiez F., Joyeux I., Galinha A., Gey A., Claret E., Sastre-Garau X., Couturier J., Mosseri V., Vives V., Banchereau J., Fridman W. H., Wijdenes J., Lebecque S., Sautès-Fridman C., Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Research 1999 59 15 3698 3704 2-s2.0-17444401702 (Pubitemid 29381875)
30. Benevides L., Cardoso C. R., Tiezzi D. G., Marana H. R., Andrade J. M., Silva J. S., Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor. European Journal of Immunology 2013 43 6 1518 1528 10.1002/eji.201242951
31. Kuang D. M., Peng C., Zhao Q., Wu Y., Chen M., Zheng L., Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology 2010 51 1 154 164 2-s2.0-73449111925 10.1002/hep.23291
32. Lv L., Pan K., Li X. D., She K., Zhao J., Wang W., Chen J., Chen Y., Yun J., Xia J., The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma. PLoS ONE 2011 6 3 2-s2.0-79953667360 10.1371/journal.pone.0018219 e18219
33. + T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology 2012 143 4 951.e8 962.e8 10.1053/j.gastro.2012.06.010
34. Le Gouvello S., Bastuji-Garin S., Aloulou N., Mansour H., Chaumette M., Berrehar F., Seikour A., Charachon A., Karoui M., Leroy K., Farcet J., Sobhani I., High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 2008 57 6 772 779 2-s2.0-44149100809 10.1136/gut.2007.123794 (Pubitemid 351716970)
35. Nam J. S., Terabe M., Kang M. J., Chae H., Voong N., Yang Y., Laurence A., Michalowska A., Mamura M., Lonning S., Berzofsky J. A., Wakefield L. M., Transforming growth factor β subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Research 2008 68 10 3915 3923 2-s2.0-45549088943 10.1158/0008-5472.CAN-08-0206
36. Numasaki M., Fukushi J., Ono M., Narula S. K., Zavodny P. J., Kudo T., Robbins P. D., Tahara H., Lotze M. T., Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003 101 7 2620 2627 2-s2.0-0037849915 10.1182/blood-2002- 05-1461 (Pubitemid 36857622)
37. Numasaki M., Watanabe M., Suzuki T., Takahashi H., Nakamura A., McAllister F., Hishinuma T., Goto J., Lotze M. T., Kolls J., Sasaki H., IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. Journal of Immunology 2005 175 9 6177 6189 2-s2.0-27144449330 (Pubitemid 41508106)
38. Gu F. M., Li Q. L., Gao Q., Jiang J., Zhu K., Huang X., Pan J., Yan J., Hu J., Wang Z., Dai Z., Fan J., Zhou J., IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Molecular Cancer 2011 10, article 150 2-s2.0-83455162844 10.1186/1476-4598-10- 150
39. Wang L., Yi T., Kortylewski M., Pardoll D. M., Zeng D., Yu H., IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. Journal of Experimental Medicine 2009 206 7 1457 1464 2-s2.0-67650495415 10.1084/jem.20090207
40. Martin-Orozco N., Muranski P., Chung Y., Yang X. O., Yamazaki T., Lu S., Hwu P., Restifo N. P., Overwijk W. W., Dong C., T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 2009 31 5 787 798 2-s2.0-70449530422 10.1016/j.immuni.2009.09.014
41. Benchetrit F., Ciree A., Vives V., Warnier G., Gey A., Sautès-Fridman C., Fossiez F., Haicheur N., Fridman W. H., Tartour E., Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 2002 99 6 2114 2121 2-s2.0-0037085768 10.1182/blood.V99.6.2114 (Pubitemid 34525496)
42. Hirahara N., Nio Y., Sasaki S., Minari Y., Takamura M., Iguchi C., Dong M., Yamasawa K., Tamura K., Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice. Oncology 2001 61 1 79 89 2-s2.0-0034909080 10.1159/000055357 (Pubitemid 32727592)
43. Hirahara N., Nio Y., Sasaki S., Takamura M., Iguchi C., Dong M., Yamasawa K., Itakura M., Tamura K., Reduced invasiveness and metastasis of Chinese hamster ovary cells transfected with human interleukin-17 gene. Anticancer Research 2000 20 5 3137 3142 2-s2.0-0033786091
44. Oshiro K., Kohama H., Umemura M., Uyttenhove C., Inagaki-Ohara K., Arakawa T., Harada M., Nakae S., Iwakura Y., Nishimaki T., Matsuzaki G., Interleukin-17A is involved in enhancement of tumor progression in murine intestine. Immunobiology 2012 217 1 54 60 2-s2.0-82155172910 10.1016/j.imbio.2011.08.002
45. Straus D. S., TNF α and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells. Molecular Cancer 2013 12 article 78 10.1186/1476-4598-12-78
46. Hyun Y. S., Han D. S., Lee A. R., Eun C. S., Youn J., Kim H., Role of IL-17A in the development of colitis-associated cancer. Carcinogenesis 2012 33 4 931 936 2-s2.0-84859602743 10.1093/carcin/bgs106
47. Wu S., Rhee K. J., Albesiano E., Rabizadeh S., Wu X., Yen H., Huso D. L., Brancati F. L., Wick E., McAllister F., Housseau F., Pardoll D. M., Sears C. L., A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature Medicine 2009 15 9 1016 1022 2-s2.0-69949120571 10.1038/nm.2015
48. Grivennikov S. I., Wang K., Mucida D., Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012 491 7423 254 258 10.1038/nature11465
49. + T cells. Scandinavian Journal of Immunology 2011 74 1 47 51 2-s2.0-79958719386 10.1111/j.1365-3083.2011.02539.x
50. Chung A. S., Wu X., Zhuang G., Ngu H., Kasman I., Zhang J., Vernes J. M., Jiang Z., Meng Y. G., Peale F. V., Ouyang W., Ferrara N., An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nature Medicine 2013 19 9 1114 1123 10.1038/nm.3291
51. + T cells promote development of cancer-initiating cells in colorectal cancer. Journal of Leukocyte Biology 2010 89 1 85 91 2-s2.0-79251557498 10.1189/jlb.0910506
52. Liu J., Duan Y., Cheng X., Chen X., Xie W., Long H., Lin Z., Zhu B., IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochemical and Biophysical Research Communications 2011 407 2 348 354 2-s2.0-79953681584 10.1016/j.bbrc.2011.03.021
53. Kryczek I., Wei S., Szeliga W., Vatan L., Zou W., Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009 114 2 357 359 2-s2.0-67651094058 10.1182/blood-2008-09-177360
54. Kinugasa T., Sakaguchi T., Gu X., Reinecker H., Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000 118 6 1001 1011 2-s2.0-0034128634 (Pubitemid 30346975)
55. Ngiow S. F., Smyth M. J., Teng M. W. L., Does IL-17 suppress tumor growth? Blood 2010 115 12 2554 2555 2-s2.0-77950582668
56. Radosavljevic G., Ljujic B., Jovanovic I., Srzentic Z., Pavlovic S., Zdravkovic N., Milovanovic M., Bankovic D., Knezevic M., Acimovic L., Arsenijevic N., Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma. Neoplasma 2010 57 2 135 144 2-s2.0-77953628124 10.4149/neo-2010-02-135
57. Sobhani I., Tap J., Roudot-Thoraval F., Roperch J. P., Letulle S., Langella P., Gérard C., van Nhieu J. T., Furet J. P., Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 2011 6 1 2-s2.0-79551571717 10.1371/journal.pone.0016393 e16393
58. Cui G., Yuan A., Goll R., Florholmen J., IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence. Scandinavian Journal of Gastroenterology 2012 47 11 1304 1312 10.3109/00365521.2012.725089
59. Wågsäter D., Löfgren S., Hugander A., Dimberg J., Expression of interleukin-17 in human colorectal cancer. Anticancer Research 2006 26 6 4213 4216 2-s2.0-33845936780 (Pubitemid 46031493)
60. Tosolini M., Kirilovsky A., Mlecnik B., Fredriksen T., Mauger S., Bindea G., Berger A., Bruneval P., Fridman W., Pagès F., Galon J., Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Research 2011 71 4 1263 1271 2-s2.0-79951815749 10.1158/0008-5472.CAN-10-2907
61. + regulatory T cells in the microenvironments of chronic inflammation and cancer. Journal of Immunology 2011 186 7 4388 4395 2-s2.0-79955040909 10.4049/jimmunol.1003251